User profiles for "author:Fabio Caputo"

Fabio Caputo

- Verified email at unife.it - Cited by 6494

Fabio Caputo

- Verified email at unisalento.it - Cited by 1407

Alcoholic liver disease–pathophysiological aspects and risk factors

A Gramenzi, F Caputo, M Biselli, F Kuria… - Alimentary …, 2006 - Wiley Online Library
Background Alcoholic liver disease has a known aetiology but a complex and incompletely
known pathogenesis. It is an extremely common disease with significant morbidity and …

Identification and management of alcohol withdrawal syndrome

A Mirijello, C D'Angelo, A Ferrulli, G Vassallo… - Drugs, 2015 - Springer
Symptoms of alcohol withdrawal syndrome (AWS) may develop within 6–24 h after the
abrupt discontinuation or decrease of alcohol consumption. Symptoms can vary from …

Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options

F Caputo, T Vignoli, L Leggio, G Addolorato… - Experimental …, 2012 - Elsevier
Alcohol-use-disorders (AUDs) afflict 1–3% of elderly subjects. The CAGE, SMAST-G, and
AUDIT are the most common and validated questionnaires used to identify AUDs in the …

Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled …

G Addolorato, L Leggio, A Ferrulli, S Cardone… - The Lancet, 2007 - thelancet.com
Background Intervention to achieve alcohol abstinence represents the most effective
treatment for alcohol-dependent patients with liver cirrhosis; however, anticraving drugs …

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study

G Addolorato, F Caputo, E Capristo… - Alcohol and …, 2002 - academic.oup.com
Aims: The γ-aminobutyric acid (GABAB) receptor agonist, baclofen, has recently been
shown to reduce alcohol intake in alcohol-preferring rats and alcohol consumption and …

Voluntary disclosure of Sustainable Development Goals in mandatory non‐financial reports: The moderating role of cultural dimension

S Pizzi, M Del Baldo, F Caputo… - Journal of International …, 2022 - Wiley Online Library
Abstract The Directive 2014/95/EU represents one of the main innovations introduced by the
European Commission to encourage large companies to disclose their contribution to …

Ability of baclofen in reducing alcohol craving and intake: II—Preliminary clinical evidence

G Addolorato, F Caputo, E Capristo… - Alcoholism: Clinical …, 2000 - Wiley Online Library
Background: Accumulating evidence shows the efficacy of the γ‐aminobutyric acid (GABAB)
receptor agonist baclofen in reducing alcohol intake in rats, but no studies have been …

Enhancing environmental information transparency through corporate social responsibility reporting regulation

F Caputo, S Pizzi, L Ligorio… - Business Strategy and …, 2021 - Wiley Online Library
This research aims to contribute to the scientific debate about the lack of interlinkages
between mandatory non‐financial reporting and sustainable business models. For our …

Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam

G Addolorato, L Leggio, L Abenavoli, R Agabio… - The American journal of …, 2006 - Elsevier
PURPOSE: Benzodiazepines are the drugs of choice in the treatment of alcohol withdrawal
syndrome (AWS). Recent data have shown that baclofen may reduce AWS symptoms. At …

Dose–response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial

G Addolorato, L Leggio, A Ferrulli… - Alcohol and …, 2011 - academic.oup.com
Aims: To explore the effect of baclofen in a dose of 20 mg three times per day, compared
with the already studied dose of 10 mg three times per day, in the treatment of alcohol …